Fasinumab

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Fasinumab
Monoclonal antibody
Type ?
Source Human
Target HNGF
Clinical data
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
KEGG
Chemical and physical data
Formula C6406H9896N1700O2026S46
Molar mass 144.6 kg/mol

Fasinumab is a human monoclonal antibody designed for the treatment of pain.[1] Fasinumab for acute sciatic pain[2]

This drug was developed by Regeneron Pharmaceuticals.

References[edit]

  1. ^ Statement On A Nonproprietary Name Adopted By The USAN Council - Fasinumab, American Medical Association.
  2. ^ http://www.dovepress.com/fasinumab-regn475-an-antinerve-growth-factor-monoclonal-antibody-for-t-peer-reviewed-article-JPR